Balentine LLC Gilead Sciences, Inc. Transaction History

Balentine LLC

$2.54 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $67,142 - $81,878	-938 Reduced 12.02%	6,867 $503,000
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $191,967 - $217,695	-2,620 Reduced 25.13%	7,805 $632,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $5,249 - $5,727	-71 Reduced 0.68%	10,425 $781,000
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $439,641 - $501,472	-5,784 Reduced 35.53%	10,496 $808,000
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $66,718 - $76,013	-863 Reduced 5.03%	16,280 $1.35 Million
Q4 2022 Jan 31, 2023	BUY	$62.32 - $89.47 $110,991 - $159,346	1,781 Added 11.59%	17,143 $1.47 Million
Q3 2022 Oct 26, 2022	SELL	$59.54 - $68.01 $356,763 - $407,515	-5,992 Reduced 28.06%	15,362 $948,000
Q2 2022 Oct 26, 2022	BUY	$57.72 - $65.01 $668,628 - $753,075	11,584 Added 118.57%	21,354 $1.32 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $1.23 Million - $1.39 Million	21,354 New	21,354 $1.32 Million
Q1 2022 Oct 26, 2022	SELL	$57.92 - $72.58 $670,945 - $840,766	-11,584 Reduced 54.25%	9,770 $581,000
Q4 2021 Oct 26, 2022	SELL	$64.88 - $73.64 $685,522 - $778,080	-10,566 Reduced 49.48%	10,788 $783,000
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $395,378 - $448,762	-6,094 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $412,502 - $445,044	6,094 New	6,094 $426,000
Q3 2020 Nov 02, 2020	SELL	$62.1 - $78.08 $163,819 - $205,975	-2,638 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $34,578 - $40,152	478 Added 22.13%	2,638 $203,000
Q1 2020 May 18, 2020	BUY	$62.63 - $80.22 $51,920 - $66,502	829 Added 62.28%	2,160 $161,000
Q4 2019 Sep 02, 2020	BUY	$61.62 - $67.78 $55,396 - $60,934	899 Added 208.1%	1,331 $86,000
Q3 2019 Nov 15, 2019	BUY	$62.51 - $69.0 $1,812 - $2,001	29 Added 7.2%	432 $27,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $24,933 - $27,960	403 New	403 $27,000
Q1 2018 May 16, 2018	SELL	$72.84 - $88.8 $11,217 - $13,675	-154 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $90,502 - $106,237	-1,272 Reduced 89.2%	154 $11,000
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $102,828 - $121,880	1,426	1,426 $116,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account